PainReform Ltd. (PRFX): Price and Financial Metrics Recent IPO
PainReform Ltd. (PRFX) Recent IPO
Today's Latest Price: $4.50 USD
Updated Nov 24 3:55pm
Add PRFX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PRFX Stock Price Chart Interactive Chart >
PRFX Price/Volume Stats
| Current price | $4.50 | 52-week high | $7.85 |
| Prev. close | $4.59 | 52-week low | $4.03 |
| Day low | $4.41 | Volume | 69,100 |
| Day high | $4.64 | Avg. volume | 77,033 |
| 50-day MA | $4.73 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 40.10M |
PainReform Ltd. (PRFX) Company Bio
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Loading social stream, please wait...